Vascular engineering using human embryonic stem cells

Biotechnology Progress

Volumn 25, Issue 1, 2009, Pages 2-9

  Hanjaya Putra, Donny ^a   Gerecht, Sharon ^a  

^a Johns Hopkins University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC ISCHEMIAS; EXTRACELLULAR MATRIX PROTEINS; GROWTH FACTORS; HUMAN EMBRYONIC STEM CELLS; HYDRODYNAMIC SHEARS; MICRO-ENVIRONMENTS; MICRO-VASCULATURE; MODEL SYSTEMS; REGENERATIVE MEDICINES; THREE-DIMENSIONAL SCAFFOLDS; VASCULAR CELLS; VASCULAR DIFFERENTIATIONS; VASCULAR DISEASE; VASCULAR ENGINEERINGS; VASCULARIZED TISSUES; VASCULOGENESIS; VASCULOGENIC;

CELL MEMBRANES; FLUID DYNAMICS; PROTEINS; THREE DIMENSIONAL; TISSUE;

TISSUE ENGINEERING;

ANGIOGENESIS; CULTURE TECHNIQUE; CYTOLOGY; EMBRYONIC STEM CELL; GENETICS; HUMAN; METHODOLOGY; PHYSIOLOGY; REVIEW; TISSUE ENGINEERING;

CELL CULTURE TECHNIQUES; EMBRYONIC STEM CELLS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; TISSUE ENGINEERING;

EID: 64549139403     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1002/btpr.129     Document Type: Article

References (86)

1. Yates C, Shepard CR, Papworth G, Dash A, Beer Stolz D, Tan-nenbaum S, Griffith L, Wells A. Novel three-dimensional organotypic liver bioreactor to directly visualize early events in metastatic progression. Adv Cancer Res. 2007;97:225-246.
2. Dressler GR. Stem cells in kidney development and regeneration. In: Lanza R, Langer R, Vacanti J, editors. Principles of Tissue Engineering, III ed. Burlington: Elsevier; 2007:787-799.
3. Sambanis A. Bioartificial Pancreas. In: Lanza R, Langer R, Vacanti J, editors. Principles ofTissue Engineering, III ed. Burlington: Elsevier; 2007:619-645.
4. Levenberg S. Engineering blood vessels from stem cells: recent advances and applications. Curr Opin Biotechnol. 2005;16:516-523.
5. Gong Z, Niklason LE. Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J. 2008;fj.07-087924.
6. Griffith LG, Naughton G. Tissue engineering-current challenges and expanding opportunities. Science 2002;295:1009-1014.
7. Sone M, Itoh H, Yamahara K, Yamashita JK, Yurugi-Kobayashi T, Nonoguchi A, Suzuki Y, Chao TH, Sawada N, Fukunaga Y, Miyashita K, Park K, Oyamada N, Taura D, Tamura N, Kondo Y, Nito S, Suemori H, Nakatsuji N, Nishikawa SI, Nakao K. Pathway for differentiation of human embryonic stem cells to vascular cell components and their potential for vascular regeneration. Arterioscler Thromb Vasc Biol. 2007;27:2127-2134.
8. Gale N, Yancopoulos G. Growth factor acting via endothelial cell-specific receptors tyrosine kinase: VEGF's, angiopoietins, and ephrins in vascular development. Genes Dev. 1999;13:1055-1077.
9. Carmeleit P, Collen D. Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development. Curr Top Microbiol Immunol. 1999;237:133-158.
10. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996;380:439-442.
11. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC. Failure of blood islands formation and vasculogenesis in Flk-1-deficient mice. Nature 1995;376:62-66.
12. Yancopoulos GD, Klagsbrun M, Folkman J. Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border. Cell 1998;93:661-664.
13. Romer LH, Birukov KG, Garcia JG. Focal adhesion: paradigm for a signaling nexus. Circ Res. 2006;98:606-616.
14. Hubbell JA. Matrix effects. In: Lanza R, Langer R, Vacanti J, editors. Principles of Tissue Engineering, III ed. Burlington: Elsevier; 2007:297-308.
15. Rongish BJ, Hinchman G, Doty MK, Baldwin HS, Tomanek RJ. Relationship of the extracellular matrix to coronary neovas-cularization during development. J Mol Cell Cardiol. 1996; 28:2203-2215.
16. Stupack DG, Cheresh DA. ECM remodeling regulates angiogen-esis: endothelial integrins look for new ligands. Science's STKE (electronic resource): signal transduction knowledge environment 2002;2002:119.
17. Hirota K, Semenza GL. Regulation of angiogenesis by hypoxia-inducible factor 1. Crit Rev Oncol Hematol. 2006;59:15-26.
18. Covello KL, Simon MC. HIFs, hypoxia, and vascular development. Curr Top Dev Biol. 2004;62:37-54.
19. Lee YM, Jeong CH, Koo SY, Son MJ, Song HS, Bae SK, Raleigh JA, Chung HY, Yoo MA, Kim KW. Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: a possible signal for vessel development. Dev Dyn. 2001;220:175-186.
20. Gassmann M, Fandrey J, Bichet S, Wartenberg M, Marti HH, Bauer C, Wenger RH, Acker H. Oxygen supply and oxygen-dependent gene expression in differentiating embryonic stem cells. Proc Natl Acad Sci USA. 1996;93:2867-2872.
21. Ramirez-Bergeron DL, Runge A, Dahl KD, Fehling HJ, Keller G, Simon MC. Hypoxia affects mesoderm and enhances heman-gioblast specification during early development. Development 2004;131:4623-4634.
22. Riha GM, Lin PH, Lumsden AB, Yao Q, Chen C. Roles of he-modynamic forces in vascular cell differentiation. Ann Biomed Eng. 2005;33:772-779.
23. Huang H, Nakayama Y, Qin K, Yamamoto K, Ando J, Yama-shita J, Itoh H, Kanda K, Yaku H, Okamoto Y, Nemoto Y. Differentiation from embryonic stem cells to vascular wall cells under in vitro pulsatile flow loading. J Artif Organs. 2005;8: 110-118.
24. Wang H, Riha GM, Yan S, Li M, Chai H, Yang H, Yao Q, Chen C. Shear stress induces endothelial differentiation from a murine embryonic mesenchymal progenitor cell line. Anterios-cler Thromb Vasc Biol. 2005;25:1817-1823.
25. Illi B, Scopece A, Nanni S, Farsetti A, Morgante L, Biglioli P, Capogrossi MC, Gaetano C. Epigenetic histone modification and cardiovascular lineage programming in mouse embryonic stem cells exposed to laminar shear stress. Circ Res. 2005; 96:501-508.
26. Metallo CM, Vodyanik MA, de Pablo JJ, Slukvin II, Palecek SP. The response of human embryonic stem cell-derived endo-thelial cells to shear stress. Biotechnol Bioeng. 2008;100:830-837.
27. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000;407:242-248.
28. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000;6:389-395.
29. Itskovitz-Eldor J, Schuldiner M, Karsenti D, Eden A, Yanuka O, Amit M, Soreq H, Benvenisty N. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med. (Cambridge, Mass.) 2000;6:88-95.
30. Gerecht-Nir S, Dazard JE, Golan-Mashiach M, Osenberg S, Botvinnik A, Amariglio N, Domany E, Rechavi G, Givol D, Itskovitz-Eldor J. Vascular gene expression and phenotypic correlation during differentiation of human embryonic stem cells. Dev Dyn. 2005;232:487-497.
31. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147.
32. Xu C, Inokuma MS, Denham J, Golds K, Kundu P, Gold JD, Carpenter MK. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol. 2001;19:971-974.
33. Ludwig TE, Levenstein ME, Jones JM, Berggren WT, Mitchen ER, Frane JL, Crandall LJ, Daigh CA, Conard KR, Piekarczyk MS, Llanas RA, Thomson JA. Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol. 2006;24:185-187.
34. Ludwig TE, Bergendahl V, Levenstein ME, Yu J, Probasco MD, Thomson JA. Feeder-independent culture of human embryonic stem cells. Nat Methods. 2006;3:637-646.
35. Ferreira LS, Gerecht S, Fuller J, Shieh HF, Vunjak-Novakovic G, Langer R. Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells. Biomaterials 2007;28:2706-2717.
36. Levenberg S, Zoldan J, Basevitch Y, Langer R. Endothelial potential of human embryonic stem cells. Blood 2007;110:806-814.
37. Ferreira LS, Gerecht S, Shieh HF, Watson N, Rupnick MA, Dallabrida SM, Vunjak-Novakovic G, Langer R. Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle-like cells and form vascular networks in vivo. Circ Res. 2007;101:286-294.
38. Levenberg S, Golub JS, Amit M, Itskovitz-Eldor J, Langer R. Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci USA. 2002;99:4391-1396.
39. Wang L, Li L, Shojaei F, Levac K, Cerdan C, Menendez P, Martin T, Rouleau A, Bhatia M. Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity 2004; 21:31-41.
40. Gerecht-Nir S, Ziskind A, Cohen S, Itskovitz-Eldor J. Human embryonic stem cells as an in vitro model for human vascular development and the induction of vascular differentiation. Lab Invest. 2003;83:1811-1820.
41. 41.Kaufman DS, Hanson ET, Lewis RL, Auerbach R, Thomson JA. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci USA. 2001;98:10716-10721.
42. Vodyanik MA, Bork JA, Thomson JA, Slukvin II. Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohe-matopoietic potential. Blood 2005;105:617-626.
43. Wang ZZ, Au P, Chen T, Shao Y, Daheron LM, Bai H, Arzigian M, Fukumura D, Jain RK, Scadden DT. Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nat Biotechnol. 2007;25:317-318.
44. Zambidis ET, Peault B, Park TS, Bunz F, Civin CI. Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development. Blood 2005; 106:860-870.
45. Aird WC. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res. 2007;100:174-190.
46. Thorgeirsson G, Robertson AL Jr. The vascular endothelium-pathobiologic significance. A review. Am J Pathol. 1978;93: 803-848.
47. Wolburg H, Neuhaus J, Kniesel U, Krauß B, Schmid EM, O?calan M, Farrell C, Risau W. Modulation of tight junction structure in blood-brain barrier endothelial cells: effects of tissue culture, second messengers and cocultured astrocytes. J Cell Sci. 1994;107:1347-1357.
48. Nagy Z, Peters H, Huttner I. Fracture faces of cell junctions in cerebral endothelium during normal and hyperosmotic conditions. Lab Invest. 1984;50:313-322.
49. Risau W. Differentiation of endothelium. FASEB J. 1995;9: 926-933.
50. Zetter BR. Endothelial heterogeneity: influence of vessel size, organ localization, and species specificity on the properties of cultured endothelial cells. In: Ryan US, editor. Endothelial Cells. Vol.II. Miami: CRC; 1987:63-80.
51. Aird WC. Endothelial cell heterogeneity. Crit Care Med. 2003;31(4 Suppl.).
52. Garlanda C, Dejana E. Heterogeneity of endothelial cells: specific markers. Arterioscler Thromb Vasc Biol. 1997;17:1193-1202.
53. Craig LE, Spelman JP, Strandberg JD, Zink MC. Endothelial cells from diverse tissues exhibit differences in growth and morphology. Microvasc Res. 1998;55:65-76.
54. Aird WC. Phenotypic heterogeneity of the endothelium: I. structure, function, and mechanisms. Circ Res. 2007;100:158-173.
55. Cho SW, Moon SH, Lee SH, Kang SW, Kim J, Lim JM, Kim HS, Kim BS, Chung HM. Improvement of postnatal neovascula-rization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Circulation 2007;116:2409-2419.
56. Lu SJ, Feng Q, Caballero S, Chen Y, Moore MA, Grant MB, Lanza R. Generation of functional hemangioblasts from human embryonic stem cells. Nat Methods. 2007;4:501-509.
57. Richardson TP, Peters MC, Ennett AB, Mooney DJ. Polymeric system for dual growth factor delivery. Nat Biotechnol. 2001; 19:1029-1034.
58. Ferreira L, Gil MH, Cabrita AMS, Dordick JS. Biocatalytic synthesis of highly ordered degradable dextran-based hydrogels. Biomaterials 2005;26:4707-4716.
59. Ferreira L, Rafael A, Lamghari M, Barbosa MA, Gil MH, Cabrita AMS, Dordick JS. Biocompatibility of chemoenzymatically derived dextran-acrylate hydrogels. J Biomed Mater Res-Part A. 2004;68:584-596.
60. Yang S, Leong KF, Du Z, Chua CK. The design of scaffolds for use in tissue engineering. Part I. Traditional factors. Tissue Eng. 2001;7:679-689.
61. Heit B, Kubes P. Measuring chemotaxis and chemokinesis: the under-agarose cell migration assay. Science (STKE) 2003;2003:l5.
62. Dang SM, Gerecht-Nir S, Chen J, Itskovitz-Eldor J, Zandstra PW. Controlled, scalable embryonic stem cell differentiation culture. Stem Cells. 2004;22:275-282.
63. Lindenhayn K, Perka C, Spitzer RS, Heilmann HH, Pommeren-ing K, Mennicke J, Sittinger M. Retention of hyaluronic acid in alginate beads: aspects for in vitro cartilage engineering. J Biomed Mater Res. 1999;44:149-155.
64. Gerecht-Nir S, Cohen S, Ziskind A, Itskovitz-Eldor J. Three-dimensional porous alginate scaffolds provide a conducive environment for generation of well-vascularized embryoid bodies from human embryonic stem cells. Biotechnol Bioeng. 2004; 88:313-320.
65. Gerecht-Nir S, Cohen S, Ziskind A, Itskovitz-Eldor J. Three-dimensional porous alginate scaffolds provide a conducive environment for generation of well-vascularized embryoid bodies from human embryonic stem cells. Biotechnol Bioeng. 2004;88: 313-320.
66. Hennink WE, De Jong SJ, Bos GW, Veldhuis TFJ, Van Nostrum CF. Biodegradable dextran hydrogels crosslinked by stereocomplex formation for the controlled release of pharmaceutical proteins. Int J Pharm. 2004;277:99-104.
67. Kim SH, Chu CC. In vitro release behavior of dextran-methac-rylate hydrogels using doxorubicin and other model compounds. J Biomater Appl. 2000;15:23-46.
68. Maia J, Ferreira L, Carvalho R, Ramos MA, Gil MH. Synthesis and characterization of new injectable and degradable dextran-based hydrogels. Polymer 2005;46:9604-9614.
69. 69.Baimeng Zhang JBW. Dextran's antithrombotic properties in small arteries are not altered by low-molecular-weight heparin or the fibrinolytic inhibitor tranexamic acid: An experimental study. Microsurgery 1993;14:289-295.
70. Osterberg E, Bergstrom K, Holmberg K, Schuman TP, Riggs JA, Burns NL, Van Alstine JM, Harris JM. Protein-rejecting ability of surface-bound dextran in end-on and side-on configurations: comparison to PEG. J Biomed Mater Res. 1995;29:741-747.
71. Massia SP, Stark J, Letbetter DS. Surface-immobilized dextran limits cell adhesion and spreading. Biomaterials 2000;21:2253-2261.
72. Thebaud NB, Pierron D, Bareille R, Le Visage C, Letourneur D, Bordenave L. Human endothelial progenitor cell attachment to polysaccharide-based hydrogels: a pre-requisite for vascular tissue engineering. J Mater Sci: Mater Med. 2007;18:339-345.
73. Rooney P, Kumar S, Ponting J, Wang M. The role of hyalur-onan in tumour neovascularization (review). Int J Cancer. 1995;60:632-636.
74. Slevin M, Kumar S, Gaffney J. Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J Biol Chem. 2002;277:41046-41059.
75. 75.Toole BP. Hyaluronan in morphogenesis. Sem Cell Dev Biol. 2001;12:79-87.
76. Slevin M, Krupinski J, Kumar S, Gaffney J. Angiogenic oligosac-charides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation. Lab Invest. 1998;78:987-1003.
77. Yang B, Hall CL, Yang BL, Savani RC, Turley EA. Identification of a novel heparin binding domain in RHAMM and evidence that it modifies HA mediated locomotion of ras-trans-formed cells. J Cell Biochem. 1994;56:455-468.
78. Gerecht S, Burdick JA, Ferreira LS, Townsend SA, Langer R, Vunjak-Novakovic G. Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc Natl Acad Sci USA. 2007;104:11298-11303.
79. Rodriguez A, Cao YL, Ibarra C, Pap S, Vacanti M, Eavey RD, Vacanti CA. Characteristics of cartilage engineered from human pediatric auricular cartilage. Plast Reconstr Surg. 1999;103:1111-1119.
80. Wu X, Rabkin-Aikawa E, Guleserian KJ, Perry TE, Masuda Y, Sutherland FWH, Schoen FJ, Mayer JE Jr, Bischoff J. Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. Am J Phys-iol-Heart Circ Physiol. 2004;287:56-52.
81. Crow BB, Borneman AF, Hawkins DL, Smith GM, Nelson KD. Evaluation of in vitro drug release, pH change, and molecular weight degradation of poly(L-lactic acid) and poly(D,L-lactide-co-glycolide) fibers. Tissue Eng. 2005;11:1077-1084.
82. Shinoka T. Tissue engineered heart valves: autologous cell seeding on biodegradable polymer scaffolds. Artif Organs. 2002;26: 402-406.
83. Levenberg S, Huang NF, Lavik E, Rogers AB, Itskovitz-Eldor J, Langer R. Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proc Natl Acad Sci USA. 2003;100:12741-12746.
84. Levenberg S, Rouwkema J, Macdonald M, Garfein ES, Kohane DS, Darland DC, Marini R, Van Blitterswijk CA, Mulligan RC, D'Amore PA, Langer R. Engineering vascularized skeletal muscle tissue. Nat Biotechnol. 2005;23:879-884.
85. Gerecht S, Townsend SA, Pressler H, Zhu H, Nijst CL, Brugge-man JP, Nichol JW, Langer R. A porous photocurable elastomer for cell encapsulation and culture. Biomaterials 2007;28:4826-4835.
86. Burdick JA, Chung C, Jia X, Randolph MA, Langer R. Controlled degradation and mechanical behavior of photopolymerized hyal-uronic acid networks. Biomacromolecules 2005;6:386-391.